Welwyn Garden City, UK (9th May 2012) Cresset, innovative provider of software and services for molecule designers is hosting its first North American User Group Meeting on May 18th, 2012. The meeting is free to attend and will be held at the Inn at Harvard in Cambridge, MA. Attendees will benefit from software training with Cresset tools, including the new Forge enhanced design and SAR interpretation program. The training will focus particularly on the needs of computational and medicinal chemists working in drug discovery. Attendees will also benefit from a series of interesting and exciting scientific presentations by both Cresset scientists and external experts.
Cresset has traditionally hosted an annual European UGM in the UK, and following the steady growth of its North American user base, the company is excited about the opportunity to provide greater support to the American market. The North American UGM is expected to become an annual event, with meetings in different cities to reach customers across the continent.
Cresset CEO, Dr Robert Scoffin said, “We are excited to continue to work with customers in the US/Canada. Not only will we share insight into our products and services but we’re delighted to have excellent speakers presenting on key scientific advancements in Chemical Phylogenetics of Histone Deacetylases and Fragment Screening.”
Scientists interested in this free event can find more details on the company’s website. Cresset’s European UGM training sessions are typically over-subscribed, so interested scientists are encouraged to register now to secure a place at the North American event.
For further information on the complete range of software and services available from Cresset, please visit www.cresset-group.com, follow Cresset on Twitter (@cressetgroup) or join the LinkedIn group.
About Cresset Group Ltd
Cresset develops software for calculating and comparing the molecular Field characteristics of chemical compounds. Field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. Cresset’s Fields provide a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s Field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 100 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com
